Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
>=30-<50
General Information
Version
1.0
Revision date
2023-04-13
Product name
Stomorgyl film-coated tablets
Product Synonyms
Stomorgyl® 2 Film-Coated Tablets, Stomorgyl® 10 Film- Coated Tablets, Stomorgyl® 20 Film-Coated Tablets, Suanatem® Forte with active ingredient: Spiramycin and Metronidazole
1.2.1 Relevant identified uses
Veterinary product
1.2.2. Uses advised against
Safety Data Sheet only for the professional user., For veteri- nary use only, Refer to the product insert for complete instruc- tions on usage
supplier name
Boehringer Ingelheim AH USA
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim AH USA
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H319, H334, H341, H351, H360, H372
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
H319
Causes serious eye irritation
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
H341
Suspected of causing genetic defects
H351
Suspected of causing cancer
H360
May damage fertility or the unborn child
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing diffi- culties if inhaled. H341 Suspected of causing genetic defects. H351 Suspected of causing cancer. H360 May damage fertility or the unborn child. H372 Causes damage to organs (Central nervous system) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P272 Contaminated work clothing must not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P285 In case of inadequate ventilation wear respiratory protec- tion.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P341 IF INHALED: If breathing is difficult, remove per- son to fresh air and keep comfortable for breathing. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical advice/ P337 + P313 If eye irritation persists: Get medical advice/ atten- P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor. P363 Wash contaminated clothing before reuse.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet). This product does not contain titanium dioxide in its respirable form and would not be considered carcinogenic; however, upon crushing, grinding or other processing that could result in the gener- ation of respirable particulates, the Category 2 carcinogenic classification would apply.
2.1 Classification of the substance or mixture
1910.1200) Eye irritation : Category 2A Respiratory sensitisation : Category 1 Skin sensitisation : Category 1 Germ cell mutagenicity : Category 2 Carcinogenicity : Category 2 Reproductive toxicity : Category 1B Specific target organ toxicity : Category 1 (Central nervous system) - repeated exposure